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Abstract
The first synthesis of the chromanone lactone dimer gonytolide A has been achieved employing 
vanadium(V)-mediated oxidative coupling of the monomer gonytolide C. An ortho-bromine 
blocking group strategy was employed to favor para-para coupling and to enable kinetic resolution 
of (±)-gonytolide C. Asymmetric conjugate reduction enabled practical kinetic resolution of a 
chiral, racemic precursor and the asymmetric synthesis of (+)-gonytolide A and its atropisomer.
Graphical Abstract
1. INTRODUCTION
Gonytolide A (1) is a dimeric chromanone natural product isolated by the Kikuchi group in 
2011.1a In an effort to search for regulators of innate immunity from natural sources, an ex 
vivo culture system based on the Drosophila immune deficiency (IMD) signaling pathway2 
identified gonytolide A as a potent innate immune promoter from the fungus Gonytrichum 
sp. Several related, non-active derivatives (gonytolides B-G, Figure 1) were co-isolated from 
the same fungal extract1b including the monomers gonytolide C (3) and gonytolide G (7). 
Gonytolide A (1) possesses four chiral centers and a chiral biaryl axis. The dimers 
gonytolide A (1), D (4) and F (6) share the same para-para linkage, whereas gonytolide B (2) 
and E (5) are connected by an ortho-para biaryl bond. The congeners gonytolides D (4) and 
E (5) are heterodimers in which one chromanone lactone is replaced by a 
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tetrahydroxanthone moiety. It was shown that gonytolide A increases TNF-α-stimulated 
production of IL-8 in human umbilical vein endothelial cells (HUVECs).1a In later studies, 
the Kikuchi group prepared simplified bischromone and bisflavone analogues3 lacking the 
lactone moiety which also promoted the mammalian TNF-α signaling pathway. One key 
structural element observed for immune-promoting activity from their SAR studies is the 
requirement for bischromanone/bischromone moieties possessing a para-para linkage, which 
in the case of gonytolide A is a crowded chiral biaryl axis which presents a formidable 
synthetic challenge.
We have previously developed methodology involving copper-mediated biaryl coupling of 
aryl stannanes to synthesize the related natural products secalonic acids A (8) and D (9) 
(Figure 1).4b However, in initial studies5 we were not successful in using this methodology 
to forge the crowded biaryl bond of gonytolide A, largely due to difficulty in accessing the 
requisite hindered aryl stannane reaction partner. Accordingly, we explored alternative 
oxidative coupling methods to construct this biologically active and synthetically 
challenging molecule in an atom- and step-economical fashion.6 The Kozlowski group has 
demonstrated the power of metal-catalyzed, oxidative coupling employing chiral copper/1,5-
diaza-cis-decalin catalysts7 to synthesize a number of perylenequinone natural products 
including cercosporin and hypocrellin.8 The Pappo group has showcased use of iron-
catalyzed, consecutive oxidative cross-couplings to prepare phlorotannin natural products.9 
In oxidative coupling of phenols, control of chemo-, regio-, and stereoselectivity are 
significant challenges. Such issues have been recently studied in a number of different 
contexts.6 For example, the Waldvogel group has developed highly efficient, anodic cross-
couplings to selectively access non-symmetric biphenols.10 The Pappo group has utilized 
chiral iron-phosphate catalysts for enantioselective homo- and cross-coupling of 2-
naphthols.11 In a recent study, Pappo and coworkers reported oxidative coupling of 
halophenols with β-keto esters in which the halogenation site influenced C-O vs. C-C 
coupling.12 The Kozlowski group has also pioneered work on selective ortho-ortho, ortho-
para, para-para oxidative homo-couplings of phenols using metal-salen complexes.13
Although para-para selective oxidative couplings have been documented using catalyst 
control by Kozlowski13 and others,14 substrates thus far have been limited to relatively 
simple phenols. In the current study, we wished to solve the regioselectivity issue for 
oxidative coupling of a complex phenolic substrate using a blocking group strategy. Our 
retrosynthetic analysis for gonytolide A is shown in Scheme 1. Dimeric chromanone 1 may 
be derived from para-para oxidative coupling of the monomer 3 in which the ortho position 
of the phenol is blocked with a halogen substituent such as bromine. It was anticipated that 
the installed halogen may also potentially stabilize developing metal phenoxyl radicals15 
during the coupling process. We considered that the oxidative coupling substrate 10 may be 
obtained from (±)-gonytolide C (3) by an asymmetric bromination/kinetic resolution 
process. Recent reports have shown significant interest in stereoselective halogenation in 
natural product synthesis16 including examples involving dynamic kinetic resolution (DKR) 
via asymmetric bromination.17 Compound 3 may be accessed using vinylogous addition of 
siloxyfuran (12) to chromone (11)4a which we have previously used to access 
tetrahydroxanthone dimers including secalonic acids 8 and 9 and rugulotrosin A.4b–d
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2. RESULTS AND DISCUSSION
We first optimized the vinylogous addition by varying both solvent and temperature (Table 
1). Chromone 11 was activated to a siloxybenzopyrylium species by treatment with 
diisopropylsilyl triflate and 2,6-lutidine which was followed by addition of siloxyfuran 12 
under various reaction conditions. The corresponding chromanone-butenolides 13 and 14 
(found to be unstable to silica gel chromatography) were produced as a mixture of 
diastereomers and were directly subjected to conjugate reduction without purification to 
afford gonytolide C (3)18 and its diastereomer 15, compounds known from our previous 
study4a to be the thermodynamic and kinetic products, respectively. Vinylogous addition in 
CH2Cl2 (0 °C) gave the best results to afford 3/15 in 66 % yield and in a 3:1 diasteromeric 
ratio (dr) (entry 1). Further raising the reaction temperature or use of other solvents resulted 
in diminished yield or negatively impacted the dr (entries 2-8).
With (±)-gonytolide C (3) in hand, we next prepared (±)-bromo-gonytolide C (10) by 
bromination with N-bromosuccinimide in CH2Cl2 at room temperature (Table 2). We 
subsequently carried out the key oxidative coupling using (±)-10. After evaluation of an 
array of commonly used metal catalysts and oxidants (Table 2), including FeCl3 (entry 1),19 
Cr-Salen (entry 3),13,20 Cu(OH)Cl-TMEDA (entry 4),21 Mn(OAc)3 (entry 5),22 PhI(OH)
(OTs) (entry 6),23 MoCl5 (entry 7)24 and a number of vanadium oxidants,25 and 
electrochemical methods (entry 12),26 we were pleased to discover that the silica gel-
supported ferric chloride (FeCl3/SiO2) (entry 2)19a and oxyvanadium trifluoride (VOF3) 
(entry 11) in TFA/TFAA27 both led to clean oxidative coupling to afford brominated dimers 
as indicated by UPLC-MS analysis.5 The crude dimers were subsequently dehalogenated 
with Pd/C under a hydrogen atmosphere to afford (±)-gonytolide A and its isomers. 
Theoretically, two homodimers (1 and 16) with C2-symmetry and two heterodimers (17 and 
18) with Cs-symmetry derived from oxidative coupling of different enantiomers may be 
produced. The FeCl3/SiO2 conditions (entry 2) afforded only trace amounts of the desired 
dimer gonytolide A, and the reaction required considerable time to reach completion (6 
days). Other conditions either gave no reaction or led to undesired byproducts.5 It should be 
noted that the VOF3-oxidative coupling of (±)-gonytolide C (3) largely afforded 
decomposition5 thereby demonstrating the importance of the halide blocking group. 
Attempts to install alternative blocking groups (e.g. benzyl, triisopropylsilyl, and tert-
butyldiphenylsilyl ethers) on the phenol of 3 failed to give the desired dimers using 
VOF3/TFA/TFAA conditions. Instead, the blocking groups were cleaved during the reaction 
and afforded complex mixtures of dimers, trimers, and tetramers derived from gonytolide C.
5
Using the VOF3/TFA/TFAA oxidative coupling conditions, (±)-gonytolide A 1 was 
produced in an 11% yield along with its atropisomer (16) in 23% yield after reductive 
debromination. In addition, the heterodimer Cs-gonytolide A (17) was produced in 23% 
yield; the corresponding Cs-atropisomer (18) was not observed. The structure of Cs-
gonytolide A (17) was confirmed by X-ray crystallographic analysis (Figure 2). 
Interestingly, the crystal structure of 17 shows out-of-plane distortion (9.4°) of the biaryl 
axis. This distortion observed in the solid state appears to occur based on minimization of 
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steric interactions (e.g. CH3 – CH3 and CH3 – CO2Me) between monomer units. Similar 
distortions have been observed in other strained biaryl systems.28
In order to eliminate the formation of a Cs-dimer during the oxidative coupling and achieve 
asymmetric synthesis of gonytolide A, access to enantiopure monomer 3 was required.4c 
Based on reported examples of asymmetric halogenation of alkenes and phenols,16,17 we 
evaluated cinchona alkaloid catalysts29 for asymmetric bromination of (±)-3. After 
considerable experimentation, we found that the dimeric catalyst (DHQD)2Pyr could achieve 
bromination of (±)-gonytolide C to effect kinetic resolution (Scheme 2). Under optimized 
conditions,5 the desired ortho-bromo gonytolide C 10 was obtained in 88:12 e.r. (16% yield) 
which after crystallization from iso-propanol slowly formed a single crystal which was 
characterized by X-ray crystallography to determine absolute stereochemistry. Given that the 
bromination site is far from point chirality, the asymmetric bromination represents an 
interesting example of remote asymmetric induction. Monomer (−)-10 bearing the incorrect 
absolute stereochemistry to access natural gonytolide was produced in an overall low yield 
due to formation of the para- and di-bromination byproducts 19 and 20.5
As shown in reported examples of asymmetric fluorination with cinchona alkaloid catalysts, 
N-fluorinated-cinchona derivatives have been characterized and identified as catalytic 
species.30 We reasoned that NBS should first brominate the tertiary nitrogen29b of the 
cinchona catalyst and that the resulting N-Br species may have a preference to recognize 
substrate enantiomers and deliver bromine to the ortho-position of 3. Accordingly, we 
conducted DFT calculations of the complex of [(DHQD)2PyrBr]+ and both enantiomers of 3 
(Figure 3). Geometry optimizations of the pre-transition state (pre-TS) at the B3LYP/LAV3P 
level showed that both enantiomers can be anchored to the N-brominated-cinchona catalyst 
through hydrogen-bonding interactions. The unnatural (−)-enantiomer of gonytolide C 
appears to be preferred in the catalyst pocket with an energy 3.2 kcal/mol lower in 
comparison to the natural (+)-enantiomer which is consistent with the observed reaction 
outcome. The difference in energy may be attributed in part to a OH-π interaction31 between 
the pyrimidine spacer and the phenol of (−)-3. For (+)-3, a weaker hydrogen bonding 
interaction is observed between the phenol and the methoxy group on the cinchona sidearm.
Although the asymmetric bromination of gonytolide C (3) provided access to an 
enantiopure, monomeric coupling substrate and enabled determination of absolute 
stereochemistry, the presence of para- and di-bromination byproducts made product 
purification somewhat tedious and lowered the isolated yield of ortho-bromide 10. Extensive 
screening of additives, solvents, bromine sources, temperature, and catalysts did not improve 
results.5 Accordingly, we considered asymmetric reduction of butenolide 13 for kinetic 
resolution, as asymmetric conjugate reductions of butenolides have been well documented 
by both the Lipshutz32 and Buchwald33 laboratories using copper hydride.34 In exploring 
these reductions, (Scheme 3) we found that butenolide 13 was very sensitive to silica gel 
chromatography and decomposed to afford an elimination product.5 Chiral HPLC analysis 
of (±)-butenolide 13 also showed partial decomposition. Further studies revealed that 13, 14, 
and the elimination product are interconvertible under basic conditions. Subsequent 
recrystallization was used to obtain pure samples of butenolides 13 and 14 and the 
elimination product from crude mixtures.5 After examination of various chiral ligands, we 
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found that the Josiphos ligand was effective at promoting CuH reduction with useful levels 
of e.r. Under optimized conditions using Josiphos SL-J001-2, (+)-gonytolide C (3) was 
produced in 49% yield and in 89:11 e.r. from (±)-butenolide 13. This material was further 
enriched to 97:3 e.r. by recrystallization and was carried forward to the bromination/
oxidative coupling/hydrogenation sequence. As expected, Cs-gonytolide A was not observed 
in the reaction, and gonytolide A was produced in 12% yield along with atrop-gonytolide A 
(35% yield).
In order to gain mechanistic insight into the VOF3-induced oxidative coupling and to 
understand the role of the halide blocking group, we carried out several mechanistic 
experiments. O-Methylation of monomer 10 afforded methyl ether substrate 21 (Scheme 3) 
which was subjected to standard oxidative coupling conditions to afford dimeric products, 
albeit in a much lower conversion than substrate 10.5 In line with literature precedents35 and 
based on the need for a blocking group and also the reactivity observed with the O-
methylated substrate 21, we propose that the oxidative dimerization may proceed through 
nucleophilic addition of 10 to an electrophilic radical cation19b (Figure 4). We propose that 
the ortho-bromide 10 may be oxidized by VOF3/TFA/TFAA to form a phenoxyl radical 
cation 22, likely through a charge transfer complex.36 The ortho-bromine may potentially 
stabilize the radical cation through electronic effects. Moreover, calculations5,37 support 
such stabilization effects by showing that the spin density can reside on the bromine atom of 
22. Unoxidized 10 may then add to the stabilized radical cation 22 to form radical cation 
intermediate 23 to initiate the coupling reaction. Intermediate 23 may undergo further 
oxidation to pre-biaryl structures 24 and 25.
We further considered that atropdiastereoselection for production of either 26 or 27 may be 
thermodynamically controlled by the relative energies of cyclohexadienone intermediates 24 
and 25. We reasoned that, during the rearomatization process, chiral information should be 
maintained. For example, conformers 24A and 25A should lead to 26 and 24B and 25B 
should afford 27, similar to the traceless chirality exchange involving rearomatization of 
dimeric 1,4-diketones reported by the Thomson group.38 In order to probe this hypothesis, 
we computed DFT energies5 for both conformers of 24/25 at the B3LYP/LACV3P level 
which showed that the precursors for bromo-atrop-gonytolide A (27) have lower relative 
energy, regardless of the C-8 configuration (Figure 4).
In addition, no interconversion of 1 and 16 was observed after thermolysis of either 
compound in refluxing toluene for 24 h. The rotational barrier for interconversion of 
atropisomers was calculated to be 47.5 kcal/mol using the B3LYP/6-31G(d) level of theory.5 
Although the rotational barrier is high, the Pappo group11a and others39 have demonstrated 
that BINOL can undergo racemization under oxidative conditions. This prompted us to 
examine single electron transfer (SET) conditions with either atrop-gonytolide A (16) or its 
brominated precursor bromo-atrop-gonytolide A (27) (Table 3). Conditions reported by 
Pappo and coworkers11a (entries 1 and 2) did not reveal any reactivity. Use of an acridinium 
photocatalyst40 under visible light conditions was found to decompose substrate 16 (entry 3) 
and led to no reaction with substrate 27 (entry 4). Use of (NH4)2Ce(NO3)6 as single electron 
oxidant did not lead to conversion of 27 to 26 (entry 5). Finally, resubjection of dimer 27 to 
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VOF3/TFA/TFAA conditions also led to decomposition (entry 6). These results are highly 
interesting given that the unnatural atropisomers 16/27 were favored during the oxidative 
coupling, but could not be isomerized to the natural atropisomers 1/26.
Finally, we evaluated various halogen blocking groups on the monomer gonytolide C (+)-3 
for examination in the VOF3-oxidative coupling in an effort to tune atropselectivity (Table 
4). Various halogen blocking groups were introduced using conventional methods, resulting 
in nearly equal amounts of para/ortho halogenation with the exception of BnMe3NICl2 
which preferentially afforded the ortho-iodide. Interestingly, a trend for atropselectivity was 
observed. Use of an ortho-iodo blocking group afforded exclusively atrop-gonytolide A 
(entry 1), while a 1:3 ratio of atropisomers in favor of atrop-gonytolide A was observed 
using a bromine blocking group (entry 2). The ratio of atropisomers increased to nearly 1:1 
employing an ortho-chlorine blocking group (entry 3). In addition, we found that use of an 
ortho-fluorine blocking group completely inhibited reactivity (entry 4). These results showed 
the critical role of halogen blocking group in the oxidative coupling, and the possibility to 
tune atropselectivity by choice of halogen. Moreover, DFT computations5 provided insight 
on how the halogen blocking group may influence atropselectivity to produce either 1 or 16. 
Figure 5 shows the disfavored model of 24A showing close proximity of the aryl bromide 
and the appended lactone moiety as well as the favored model of 24B where the bromine is 
proximal to a methyl ester. This steric analysis is also consistent with the atropselectivity 
trend observed from I → Br → Cl blocking groups in which greater amounts of gonytolide 
A are observed. Unfortunately, attempts to use chiral ligands41 or a chiral oxovanadium 
complexes42 in oxidative coupling of 10 to further tune the atropselectivity failed to yield 
dimers.5 These results are not surprising as the mechanism suggests an outer-sphere 
oxidation process.43
3. CONCLUSION
In conclusion, we have synthesized the natural product (+)-gonytolide A and its unnatural 
atropisomer (-)-atrop-gonytolide A in five steps from a chromone ester monomer. The 
synthesis features vinylogous addition to rapidly construct a chromanone butenolide 
substrate, asymmetric conjugate reduction/asymmetric bromination to resolve a chiral, 
racemic butenolide monomer, and oxidative coupling using a halide blocking group to 
construct the crowded biaryl linkage of the dimer gonytolide A and its atropisomer. The 
halogen blocking group appears to have several different roles in the oxidative coupling: 1) 
stabilization of radical cation intermediates, 2) control of para-para coupling selectivity, and 
3) steric tuning of atropdiastereoselection providing access to both natural and unnatural 
atropisomers in varying ratios depending on the halogen blocking group. Further studies on 
the syntheses and biology of dimeric chromanones and derivatives are currently ongoing in 
our lab and will be reported in due course.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Wu et al. Page 6
J Am Chem Soc. Author manuscript; available in PMC 2019 May 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Acknowledgments
We thank the National Institutes of Health (R35 GM-118173) for research support. Work at the BU-CMD is 
supported by the NIH R24 grant GM-111625. We thank Prof. Scott Miller and Dr. Anthony Metrano (Yale 
University) for helpful discussions and preliminary experiments. We thank the Uehara Memorial Foundation for a 
postdoctoral fellowship to T.I., the American Cancer Society for a postdoctoral fellowship to K.D.R. 
(PF-16-235-01-CDD), and Dr. Jeffrey Bacon (Boston University) for X-ray crystal structure analyses. We thank 
Prof. Haruhisa Kikuchi (Tohoku University) for providing a natural sample of gonytolide A. NMR (CHE-0619339) 
and MS (CHE-0443618) facilities at Boston University are supported by the NSF.
References
1. (a) Kikuchi H, Isobe M, Sekiya M, Abe Y, Hoshikawa T, Ueda K, Kurata S, Katou Y, Oshima Y. 
Org Lett. 2011; 13:4624. [PubMed: 21827134] (b) Kikuchi H, Isobe M, Kurata S, Katou Y, Oshima 
Y. Tetrahedron. 2012; 68:6218.(c) Maha A, Rukachaisirkul V, Phongpaichit S, Poonsuwan W, 
Sakayaroj J. Tetrahedron. 2016; 72:2874.
2. (a) Yajima M, Takada M, Takahashi N, Kikuchi H, Natori S, Oshima Y, Kurata S. Biochem J. 2003; 
371:205. [PubMed: 12513692] (b) Sekiya M, Ueda K, Fujita T, Kitayama M, Kikuchi H, Oshima Y, 
Kurata S. Life Sci. 2006; 80:113. [PubMed: 16978662] 
3. Kikuchi H, Hoshikawa T, Kurata S, Katou Y, Oshima Y. J Nat Prod. 2016; 79:1259. [PubMed: 
27082979] 
4. (a) Qin T, Johnson RP, Porco JA Jr. J Am Chem Soc. 2011; 133:1714. [PubMed: 21265529] (b) Qin 
T, Porco JA Jr. Angew Chem Int Ed. 2014; 53:3107.(c) Qin T, Skraba-Joiner SL, Khalih ZG, 
Johnson RP, Capon RJ, Porco JA Jr. Nat Chem. 2015; 7:234. [PubMed: 25698333] (d) Qin T, Iwata 
T, Ransom TT, Beutler JA, Porco JA Jr. J Am Chem Soc. 2015; 137:15225. [PubMed: 26544765] 
5. See Supporting Information for complete experimental details.
6. Kozlowski MC. Acc Chem Res. 2017; 50:638. [PubMed: 28945389] 
7. (a) Li X, Yang J, Kozlowski MC. Org Lett. 2001; 3:1137. [PubMed: 11348178] (b) Hewgley JB, 
Stahl SS, Kozlowski MC. J Am Chem Soc. 2008; 130:12232. [PubMed: 18710234] 
8. (a) Mulrooney CA, Li X, Divirgilio ES, Kozlowski MC. J Am Chem Soc. 2003; 125:6856. 
[PubMed: 12783524] (b) Divirgilio ES, Dugan EC, Mulrooney CA, Kozlowski MC. Org Lett. 2007; 
9:385. [PubMed: 17249768] (c) O’Brien EM, Morgan BJ, Kozlowski MC. Angew Chem Int Ed. 
2008; 47:6877.(d) Morgan BJ, Dey S, Johnson SW, Kozlowski MC. J Am Chem Soc. 2009; 
131:9413. [PubMed: 19489582] (e) Morgan B, Mulrooney CA, O’Brien EM, Kozlowski MC. J Org 
Chem. 2010; 75:30. [PubMed: 19894745] 
9. Vershinin V, Dyadyuk A, Pappo D. Tetrahedron. 2017; 73:3660.
10. (a) Riehl B, Dyballa K, Franke R, Waldvogel SR. Synthesis. 2016; 49:252.(b) Wiebe A, 
Schollmeyer D, Dyballa KM, Franke R, Waldvogel SR. Angew Chem Int Ed. 2016; 55:11801.(c) 
Lips S, Wiebe A, Elsler B, Schollmeyer D, Dyballa KM, Franke R, Waldvogel SR. Angew Chem 
Int Ed. 2016; 55:10872.(d) Schulz L, Enders M, Elsler B, Schollmeyer D, Dyballa KM, Franke R, 
Waldvogel SR. Angew Chem Int Ed. 2017; 56:4877.
11. (a) Narute S, Parnes R, Toste FD, Pappo D. J Am Chem Soc. 2016; 138:16553. [PubMed: 
27959518] (b) Forkosh H, Vershinin V, Reiss H, Pappo D. Org Lett ASAP. 
12. Regev A, Shalit H, Pappo D. Synthesis. 2015; 47:1716.
13. Lee YE, Cao T, Torruellas C, Kozlowski MC. J Am Chem Soc. 2014; 136:6782. [PubMed: 
24797179] 
14. (a) Carrick WL, Karapinka GL, Kwiatkowski GT. J Org Chem. 1968; 33:2388.(b) Sperry J, 
Sejberg JJP, Stiemke FM, Brimble MA. Org Biomol Chem. 2009; 7:2599. [PubMed: 19503935] 
(c) Shalit H, Libman A, Pappo D. J Am Chem Soc. 2017; 139:13404. [PubMed: 28862442] 
15. Shimazaki Y, Yamauchi O. Indian J Chem. 2011; 50A:383.
16. (a) Hu DX, Shibuya GM, Burns NZ. J Am Chem Soc. 2013; 135:12960. [PubMed: 23952929] (b) 
Hu DX, Seidl FJ, Bucher C, Burns NZ. J Am Chem Soc. 2015; 137:3795. [PubMed: 25738419] 
(c) Bucher C, Deans RM, Burns NZ. J Am Chem Soc. 2015; 137:12784. [PubMed: 26394844] (d) 
Landry ML, Hu DX, McKenna GM, Burns NZ. J Am Chem Soc. 2016; 138:5150. [PubMed: 
Wu et al. Page 7
J Am Chem Soc. Author manuscript; available in PMC 2019 May 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
27018981] (e) Burckle AJ, Vasilev VH, Burns NZ. Angew Chem Int Ed. 2016; 55:11476.(f) 
Samanta R, Yamamoto H. J Am Chem Soc. 2017; 139:1460. [PubMed: 28059507] 
17. (a) Barrett KT, Miller SJ. J Am Chem Soc. 2013; 135:2963. [PubMed: 23410090] (b) Mori K, 
Ichikawa Y, Kobayashi M, Shibata Y, Yamanaka M, Akiyama T. J Am Chem Soc. 2013; 135:3964. 
[PubMed: 23413828] (c) Barrett KT, Metrano AJ, Rablen PR, Miller SJ. Nature. 2014; 509:71. 
[PubMed: 24747399] (d) Miyaji R, Asano K, Matsubara S. J Am Chem Soc. 2015; 137:6766. 
[PubMed: 26000800] (e) Diener ME, Metrano AJ, Miller SJ. J Am Chem Soc. 2015; 137:12369. 
[PubMed: 26343278] 
18. Syntheses of gonytolide C: Tietze LF, Jackenkroll S, Hierold J, Ma L, Waldecker B. Chem Eur J. 
2014; 20:8628. [PubMed: 24905446] Sudhakar G, Bayya S, Kadam VD, Nanubolu JB. Org 
Biomol Chem. 2014; 12:5601. [PubMed: 24953777] Liu J, Li Z, Tong P, Xie Z, Zhang Y, Li Y. J 
Org Chem. 2015; 80:1632. [PubMed: 25560746] Li FF, Atkinson DJ, Furkert DP, Brimble MA. 
Eur J Org Chem. 2016; 1145
19. (a) Li H-Y, Nehira T, Hagiwara M, Harada N. J Org Chem. 1997; 62:7222. [PubMed: 11671832] 
(b) Libman A, Shalit H, Vainer Y, Narute S, Kozuch S, Pappo D. J Am Chem Soc. 2015; 
137:11453. [PubMed: 26287435] 
20. (a) Katsuki T. Chem Soc Rev. 2004; 33:437. [PubMed: 15354225] (b) Cozzi PG. Chem Soc Rev. 
2004; 33:410. [PubMed: 15354222] 
21. (a) Noji M, Nakajima M, Koga K. Tetrahedron Lett. 1994; 35:7983.(b) Nakajima M, Miyoshi I, 
Kanayama K, Hashimoto S, Noji M, Koga K. J Org Chem. 1999; 64:2264.(c) O’Brien EM, 
Morgan BJ, Kozlowski MC. Angew Chem Int Ed. 2008; 47:6877.(d) Yan P, Sugiyama Y, 
Takahashi Y, Kinemuchi H, Temma T, Habaue S. Tetrahedron. 2008; 64:4325.
22. Wang K, Hu Y, Li Z, Wu M, Liu Z, Su B, Yu A, Liu Y, Wang Q. Synthesis. 2010; 7:1083.
23. (a) Dohi T, Ito M, Morimoto K, Iwata M, Kita Y. Angew Chem Int Ed. 2008; 47:1301.(b) 
Morimoto K, Ohnishi Y, Koseki D, Nakamura A, Dohi T, Kita Y. Org Biomol Chem. 2016; 
14:8947. [PubMed: 27722732] 
24. Schubert M, Leppin J, Wehming K, Schollmeyer D, Heinze K, Waldvogel SR. Angew Chem Int 
Ed. 2014; 53:2494.
25. Hirao T. Chem Rev. 1997; 97:2707. [PubMed: 11851478] 
26. Kirste A, Elsler B, Schnakenburg G, Waldvogel SR. J Am Chem Soc. 2012; 134:3571. [PubMed: 
22242769] 
27. (a) Kupchan SM, Dhingra OP, Kim CK. J Org Chem. 1978; 43:4076.(b) Evans DA, Wood MR, 
Trotter BW, Richardson TI, Barrow JC, Katz JL. Angew Chem Int Ed. 1998; 37:2700.
28. (a) Colquhoun, HM., Dudman, CC., Thomas, M., O’Mahoney, CA., Williams, DJ. J Chem Soc, 
Chem Commun. 1990. p. 336(b) Burns N, Krylova IN, Hannoush RN, Baran PS. J Am Chem Soc. 
2009; 131:9172. [PubMed: 19530671] (c) Konkol LC, Guo F, Sarjeant AA, Thomson RJ. Angew 
Chem Int Ed. 2011; 50:9931.(d) Liau BB, Milgram BC, Shair MD. J Am Chem Soc. 2012; 
134:16765. [PubMed: 22970979] (e) Mitra NK, Meudom R, Corzo HH, Gorden JD, Merner BL. J 
Am Chem Soc. 2016; 138:3235. [PubMed: 26866502] 
29. (a) Chen ZM, Zhang QW, Chen ZH, Li H, Tu YQ, Zhang FM, Tian JM. J Am Chem Soc. 2011; 
133:8818. [PubMed: 21548637] (b) Zhang X, Li J, Tian H, Shi Y. Chem Eur J. 2015; 21:11658. 
[PubMed: 26137926] 
30. (a) Shibata N, Suzuki E, Takeuchi Y. J Am Chem Soc. 2000; 122:10728.(b) Shibata N, Suzuki E, 
Asahi T, Shiro M. J Am Chem Soc. 2001; 123:7001. [PubMed: 11459478] (c) Shibata N, Ishimaru 
T, Suzuki E, Kirk K. J Org Chem. 2003; 68:2494. [PubMed: 12636425] 
31. (a) Mileni M, Garfunkle J, Ezzili C, Kimball FS, Cravatt BF, Stevens RC, Boger DL. J Med Chem. 
2010; 53:230. [PubMed: 19924997] (b) Howie R, Lima C, Kaiser C, de Souza M, Wardell J, 
Wardell S. Z Kristallogr. 2010; 225:349.
32. (a) Lipshutz BH, Servesko JM, Taft BR. J Am Chem Soc. 2004; 126:8352. [PubMed: 15237972] 
(b) Lipshutz BH, Frieman BA. Angew Chem Int Ed. 2005; 44:6345.
33. (a) Hughes G, Kimura M, Buchwald SL. J Am Chem Soc. 2003; 125:11253. [PubMed: 16220945] 
(b) Rainka MP, Milne JE, Buchwald SL. Angew Chem Int Ed. 2005; 44:6177.
34. (a) Rendler S, Oestreich M. Angew Chem Int Ed. 2007; 46:498.(b) Deutsch C, Krause N, Lipshutz 
B. Chem Rev. 2008; 108:2916. [PubMed: 18616323] 
Wu et al. Page 8
J Am Chem Soc. Author manuscript; available in PMC 2019 May 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
35. For radical cation mechanisms in biaryl coupling, see: Tanaka M, Nakashima H, Fujiwara M, Ando 
H, Souma Y. J Org Chem. 1996; 61:788. [PubMed: 11667008] Schubert M, Franzmann P, 
Wunsche von Leupoldt A, Koszinowski K, Heinze K, Waldvogel SR. Angew Chem Int Ed. 2016; 
55:1156.
36. Hamamoto H. Chem Pharm Bull. 2012; 60:799. [PubMed: 22790811] 
37. Morofuji T, Shimizu A, Yoshida J. Angew Chem Int Ed. 2012; 51:7259.
38. Guo F, Konkol LC, Thomson RJ. J Am Chem Soc. 2011; 133:18. [PubMed: 21141997] 
39. (a) Brussee J, Jansen AC. Tetrahedron. 1983; 24:3261.(b) Smrcina M, Polakova J, Vyskocil S, 
Kocovsky P. J Org Chem. 1993; 58:4534.(c) Qi C, Wang W, Reichl KD, McNeely J, Porco JA Jr. 
Angew Chem Int Ed. 2018; 57:2101.
40. Fukuzumi S, Kotani H, Ohkubo K, Ogo S, Tkachenko NV, Lemmetyinen H. J Am Chem Soc. 
2004; 126:1600. [PubMed: 14871068] 
41. Habaue S, Murakami S, Higashimura H. J Polym Sci A Polym Chem. 2005; 43:5872.
42. (a) Takizawa S, Katayama T, Sasai H. Chem Commun. 2008; 0:4113.(b) Kang H, Lee YE, Reddy 
PVG, Dey S, Allen SE, Niederer KA, Sung P, Kirsten H, Torruellas C, Herling MR, Kozlowski 
MC. Org Lett. 2017; 19:5505. [PubMed: 29022352] 
43. (a) Dick AR, Sanford MS. Tetrahedron. 2006; 62:2439.(b) Hashizume S, Oisaki K, Kanai M. 
Chem Rec. 2011; 11:236. [PubMed: 21898780] 
Wu et al. Page 9
J Am Chem Soc. Author manuscript; available in PMC 2019 May 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Gonytolide A and Related Natural Products
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Figure 2. 
X-ray Crystal Structure of Cs-gonytolide A (17)
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Figure 3. 
Models for Asymmetric Bromination of 3
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Figure 4. 
Proposed Mechanism for Oxidative Coupling
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Figure 5. 
Space Filling Models for Biaryl Precursors
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Scheme 1. 
Inital Retrosynthetic Analysis for 1
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Scheme 2. 
Attempted Asymmetric Bromination
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Scheme 3. 
Asymmetric Conjugate Reduction and Synthesis of (+)-Gonytolide A
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Table 1
Evaluation of the Vinylogous Addition
entry temperature solvent overall yield (3+15) dr(3 : 15)
1 0°C CH2Cl2 66% 3 : 1
2 rt CH2Cl2 57% 3 : 1
3 reflux CH2Cl2 54% 3 : 1
4 0°C THF 60% 1 : 5
5 0°C Et2O/CH2Cl2(2 : 1) 39% 2 : 1
6 0°C toluene 47% 1 : 4
7 rt benzene 52% 1 : 1
8 rt MeCN 24% 3 : 1
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Table 2
Oxidative Coupling of (±)-gonytolide C (3)
entry conditionsa results
1 0.1 equiv. FeCl3, 2.5 equiv. t-BuOOt-Bu, HFIP, rt No reaction
2 FeCl3/SiO2, 70 °C, no solvent, 6 days <5% 1, 19% 17, 28% 16
3 1.0 equiv. Cr-salen, DCE, O2, 70 °C No reaction
4 1.0 equiv. Cu(OH)Cl-TMEDA, DCE, O2, 70 °C Decomposition
5 1.0 equiv. Mn(OAc)3, AcOH, rt No reaction
6 0.5 equiv. PhI(OH)(OTs), HFIP, rt Complex mixture
7 4.0 equiv. MoCl5, CH2Cl2, rt Para-chlorination of 10
8 2.0 equiv. VOCl3, THF, rt Para-chlorination of 10
9 2.0 equiv. VOSO4, CH2Cl2, O2, rt No reaction
10 2.0 equiv. VOF3, HFIP, rt No reaction
11 2.5 equiv. VOF3, TFA/TFAA, rt 11% 1, 23% 17, 23% 16
12 Divided cell, graphite anode, TFE/H2O 4:1, 0.2 M LiClO4, 1.0 mA, 3.0~4.0 V Decomposition
a
Reaction conducted for 12 h unless specified otherwise.
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Table 3
Attempted Atropisomerism of Gonytolide Dimers
entry X conditionsa results
1 H 0.1 equiv. FeCl3, DCE/HFIP 1:1, rt No reaction
2 Br 0.1 equiv. FeCl3, 1.5 equiv. t-BuOOt-Bu, DCE/HFIP 1:1, rt No reaction
3 H 0.1 equiv. 9-mesityl-10-methylacridinium tetra-fluoroborate, CH3CN, 427 nm, rt Complete decomposition
4 Br 0.1 equiv. 9-mesityl-10-methylacridinium tetra-fluoroborate, CH3CN, 427 nm, rt No reaction
5 Br 0.5 equiv. (NH4)2Ce(NO3)6, CH3CN/H2O 1:1, rt Decomposition
6 Br 0.5 equiv. VOF3, TFA/TFAA 20:1, rt Complete decomposition
a
Reaction conducted for 12 h unless specified otherwise.
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Table 4
Oxidative Coupling Using Various Halogen Blocking Groups
Entry Conditionsa Halogenation results Coupling results
1 BnMe3NICl2, CaCO3, CH2Cl2/CH3OH, rt 70%, X= I 0% 1, 25% 16
2 NBS, CH2Cl2, rt 53%, X= Br 11% 1, 35% 16
3 NCS, DMF, 60 °C 4 h 44%, X= Cl 23% 1, 27% 16
4 Selectfluor®, CH3CN, rt 31%, X= F No reaction
a
Reaction conducted for 12 h unless specified otherwise.
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